J&J’s $16.6B Deal for Abiomed Indicators a New Concentration on Medtech
Johnson & Johnson introduced an eye-popping health care-product enterprise acquisition early Tuesday, having to pay $16.6 billion upfront for Abiomed ...
Read moreDetailsJohnson & Johnson introduced an eye-popping health care-product enterprise acquisition early Tuesday, having to pay $16.6 billion upfront for Abiomed ...
Read moreDetailsJ&J Agrees to Obtain Health care-System Maker Abiomed
Read moreDetailsEmail Contact: souhaib@trendswide.com